Tailored vs. Empirical Helicobacter Pylori Infection Treatment

Conditions: Helicobacter Pylori Infection Interventions: Diagnostic Test: Clarithromycin (mutations in the 23S rRNA gene, A2134G, A2142G and A2142C mutations) and levofloxacin resistance (mutations in the gyrA gene) PCR test; Drug: Empirically H. pylori eradication treatment with bismuth quadruple therapy (Pylera ®); Drug: PPI, amoxicillin 1 g and clarithromycin 500 mg, twice daily, for 10 days; Drug: PPI, amoxicillin 1g and levofloxacin 250 mg, twice daily, for 10 days; Drug: Bismuth quadruple therapy (Pylera®) for 10 days Sponsors: Manuel Coelho da Rocha Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials